定量MRI弛豫时间血栓时相生物标志物的组织学验证:可行性研究
该可行性研究对14例临床干预中新鲜取出的入静脉血栓在9.4T下离体行定量MRI,并以组织学像素阈值法定量红细胞、纤维蛋白/血小板及胶原/ECM。结果显示T1与红细胞含量强负相关,T2与T2*与血栓年龄负相关,纤维化血栓胶原/ECM更高且组织化评分更高。
要点
- T1主要反映红细胞富集的血栓成分。
- T2与T2*随血栓年龄增加而缩短。
- 纤维化血栓更陈旧、红细胞少且组织化评分高。
核心结论
- 定量MRI弛豫时间可反映不同血栓表型,T1主要捕捉红细胞富集成分,T2与T2*反映血栓年龄、组织化及纤维化重塑。
研究设计与样本
- 可行性研究,对14例临床干预中新鲜取出的入静脉血栓在福尔马林固定前于9.4T行离体MRI。
- 采用快速采集弛豫增强序列测T1、多层多回波成像测T2、多梯度回波成像测T2*,并以像素阈值法量化组织学成分。
- 使用Spearman相关和Mann-Whitney U检验分析临床血栓年龄、MRI弛豫时间与组织学参数间的关联。
主要发现
- 14例中11例血栓在症状发作或就诊后14天内取出,另3例间隔分别为36、73和104天。
- 患者平均年龄58.9 ± 13.6岁,平均体重指数31.0 ± 5.3 kg/m2。
- T1、T2、T2*的中位弛豫时间分别为1719.2 ms、81.1 ms和9.48 ms。
- 血栓年龄增加与T2缩短相关(r = -0.676;P = .00792),与T2*缩短相关(r = -0.676;P = .0194),与T1无关(r = +0.330;P = .249)。
- T1与红细胞含量呈强负相关(r = -0.765;P = .00143);组织学成分异质,红细胞含量1%至89%,纤维蛋白/血小板10%至65%,胶原/ECM 0%至89%。
关键数值与推荐
- ≥14天血栓的T2值低于<14天血栓(58.5 vs 83.4 ms;P = .0360)。
- 纤维化血栓胶原/ECM含量更高(39.0% vs 0.0%;P = .00078),更陈旧(25 vs 4天;P = .0111),红细胞含量更低(17.3% vs 64.0%;P = .0166),组织化评分更高(3.0 vs 0.5;P = .00453)。
临床怎么用
- 症状持续时间作为血栓生物学替代指标不精确,定量MRI弛豫测量有望未来用于血栓切除或溶栓前的无创血栓表型评估。
- 当前结果来自9.4T离体研究,需在临床可用较低场强下前瞻性验证后方可用于患者选择。
局限性
- 研究为离体高场强(9.4T)可行性研究,样本量14例,需在临床较低场强下前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medical anticoagulation remains the standard treatment for venous thromboembolism, but mechanical thrombectomy is increasingly used in selected patients. Patient selection remains limited because thrombus age, composition, organization, and fibrosis are difficult to determine before intervention. OBJECTIVE: To evaluate whether quantitative magnetic resonance imaging (MRI) relaxation times correlate with histologic thrombus composition and remodeling in freshly retrieved ex vivo human venous thrombi. METHODS: Fourteen fresh human venous thrombi retrieved during clinical intervention were imaged ex vivo at 9.4 T before formalin fixation. T1 relaxation times were measured using rapid acquisition with relaxation enhancement, T2 using multislice multiecho imaging, and T2∗ using multigradient echo imaging. Digitized histology slides were analyzed with pixel-thresholding to quantify red blood cell (RBC), fibrin/platelet, and collagen/extracellular matrix (ECM) content. Fibrosis and organization were scored semiquantitatively. Associations between clinical thrombus age, MRI relaxation times, and histologic parameters were assessed using Spearman correlations and Mann-Whitney U tests. RESULTS: Of 14 patients, 11 thrombi were retrieved within 14 days of symptom onset or presentation, whereas three had longer intervals of 36, 73, and 104 days. Mean patient age was 58.9 ± 13.6 years, and mean body mass index was 31.0 ± 5.3 kg/m2. Median relaxation times were 1719.2 ms for T1, 81.1 ms for T2, and 9.48 ms for T2∗. Increasing thrombus age correlated with shorter T2 (r = -0.676; P = .00792) and T2∗ (r = -0.676; P = .0194), but not with T1 (r = +0.330; P = .249). T1 showed a strong inverse correlation with RBC content (r = -0.765; P = .00143). Histologic composition was heterogeneous, with RBC content ranging from 1% to 89%, fibrin/platelet content from 10% to 65%, and collagen/ECM content from 0% to 89%. Thrombi ≥14 days had lower T2 values than thrombi <14 days (58.5 vs 83.4 ms; P = .0360). Fibrotic thrombi had higher collagen/ECM content (39.0% vs 0.0%; P = .00078), were older (25 vs 4 days; P = .0111), had lower RBC content (17.3% vs 64.0%; P = .0166), and showed higher organization scores (3.0 vs 0.5; P = .00453). CONCLUSIONS: Quantitative MRI relaxation times reflect distinct thrombus phenotypes. T1 primarily captures RBC-rich composition, whereas T2 and T2∗ reflect thrombus age, organization, and fibrotic remodeling. This histology-validated ex vivo high-field-strength framework may provide a basis for prospective validation at clinically available lower field strengths, with the ultimate goal of evaluating MRI-based patient selection for venous thrombectomy. CLINICAL RELEVANCE: Patient selection for venous intervention remains challenging because symptom duration is an imprecise surrogate for thrombus biology. In clinical practice, thrombi with similar reported age may differ substantially in red blood cell content, collagen deposition, fibrosis, and organization, factors that are likely relevant to mechanical behavior and treatment response. In this feasibility study, quantitative magnetic resonance relaxation times measured in freshly retrieved human venous thrombi were histologically validated against thrombus composition and remodeling. T1 was most strongly associated with red blood cell-rich thrombus composition, whereas T2 and T2∗ were more closely associated with thrombus age, collagen/extracellular matrix deposition, fibrosis, and organization. These findings support quantitative magnetic resonance relaxometry as a candidate biomarker-based approach to thrombus chronicity and phenotype, with potential future value for improving preprocedural characterization of thrombi before thrombectomy or thrombolysis. Although this work was performed ex vivo at 9.4 T, it establishes biologic feasibility and a translational framework for subsequent validation at lower clinical field strengths, with the long-term goal of bringing thrombus phenotyping closer to a more precise clinical decision-making.
引用
- Pomozi E, Jordan C, Crichton A, et al. Histologic validation of quantitative magnetic resonance relaxation time biomarkers for thrombus chronicity: A feasibility study. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42749256. doi:10.1016/j.jvsv.2026.102620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。